CDK4 and glioma: Interestingly, miR-124 inhibited the migration and invasion of glioma cells through down-regulation of ROCK1, SOS1, CDK4, STAT3, and PPP1R13L expression [37–40], indicating miR-124 may be a valuable biomarker for glioma.